Neurological Disease Severity Assessment Study

Full Study Name

Neurological Disease Severity Assessment Study


University of Manchester

Local Principal Investigator

Aimee Donald

Study Status


Main Aims

To evaluate the use of new technology as a way of monitoring disease severity in patients with neurological diseases.

Inclusion Criteria
  • Over the age of five years
  • Be able to participate in more than three of the study procedures
  • Written Ethics Committee (EC) approved informed consent obtained from the patient, or patient’s parent or legal
  • Guardian and patient assent if appropriate
Exclusion Criteria
  • Unrelated co-morbid condition limiting life expectancy to less than 6 months
  • Patient or if applicable, parent or legal guardian is unable to comprehend, sign and date the EC approved informed
  • Consent form and patient assent as appropriate
  • If determined unsuitable for the study by the investigator
Open Sites

Manchester, Royal Free, Great Ormond Street, Cambridge, UCLH

For more information click here